To test this hypothesis, we treated UHRF1-depleted CRC cells with trichostatin A (TSA), a HDAC inhibitor, and assessed the expression of well-characterized tumor suppressor genes silenced by CpG island hypermethylation. This evidence concerns the gene HDAC9 and neoplasm.